Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07214428 · ClinicalTrials.gov registry record · NA

Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students

A NA study of Psychological Distress and Gut -Microbiota, sponsored by Rutgers, The State University of New Jersey.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07214428: Active NA study of Psychological Distress and Gut -Microbiota, sponsored by Rutgers, The State University of New Jersey.

NCT07214428 is a NA study of Psychological Distress and Gut -Microbiota that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 50 participants, below the 471-participant average among 28 other Psychological Distress trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07214428, a NA study of Psychological Distress and Gut -Microbiota, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this trial is to investigate the effect of freeze-dried table grape powder (FTGP) on psychological distress and gut microbiota in college students. The main questions it aims to answer are: Does FTGP reduce anxiety, depression, and perceived stress? Does FTGP improve the gut microbiota? Researchers will compare FTGP to a placebo to see how FTGP affects psychological distress and gut microbiota. Participants will: Drink a daily supplement containing FTGP or a placebo for 4 weeks. Record consumption of grape powder or placebo in a compliance log. Complete surveys and provide stool samples. Three in-person visits.

Primary Outcome

HAMA-14 is one of the earliest and most widely used clinical scales for measuring the severity of a patient's anxiety. It has 14 items, each reflecting a cluster of anxiety symptoms. Total range: 0 to 56, with higher scores indicating greater severity of anxiety

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT freeze-dried table grape powder

Study Locations (1)

New Jersey

  • Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers, The State University of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10-20
Est. Completion 2026-05-30
Phase NA

What the registry record for NCT07214428 still lists

NCT07214428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 471-participant average among 28 other Psychological Distress trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Psychological Distress appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07214428 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT07214428 about?

NCT07214428 is a clinical study titled "Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students". The goal of this trial is to investigate the effect of freeze-dried table grape powder (FTGP) on psychological distress and gut microbiota in college students. The main questions it aims to answer are: Does FTGP reduce anxiety, depression, and perceived stress? Does FTGP improve the gut microbiota?...

What is the current status of trial NCT07214428?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-20. Estimated completion is 2026-05-30.

What conditions does trial NCT07214428 study?

This clinical trial studies the following conditions: Psychological Distress, Gut -Microbiota.

What interventions are being tested in trial NCT07214428?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), freeze-dried table grape powder (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07214428?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07214428 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychological Distress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07214428's enrollment target sits among peer trials

50 18th of 28 higher than 10 of 28 other Psychological Distress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychological Distress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07214428, the US trial registry maintained by the National Library of Medicine. NCT07214428 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.